BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 26544730)

  • 1. Beyond proliferation: KLF5 promotes angiogenesis of bladder cancer through directly regulating VEGFA transcription.
    Gao Y; Wu K; Chen Y; Zhou J; Du C; Shi Q; Xu S; Jia J; Tang X; Li F; Hui K; He D; Guo P
    Oncotarget; 2015 Dec; 6(41):43791-805. PubMed ID: 26544730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KLF5 promotes cell proliferation and tumorigenesis through gene regulation and the TSU-Pr1 human bladder cancer cell line.
    Chen C; Benjamin MS; Sun X; Otto KB; Guo P; Dong XY; Bao Y; Zhou Z; Cheng X; Simons JW; Dong JT
    Int J Cancer; 2006 Mar; 118(6):1346-55. PubMed ID: 16184550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenoviral mediated interferon-alpha 2b gene therapy suppresses the pro-angiogenic effect of vascular endothelial growth factor in superficial bladder cancer.
    Adam L; Black PC; Kassouf W; Eve B; McConkey D; Munsell MF; Benedict WF; Dinney CP
    J Urol; 2007 May; 177(5):1900-6. PubMed ID: 17437845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KLF5 promotes cell migration by up-regulating FYN in bladder cancer cells.
    Du C; Gao Y; Xu S; Jia J; Huang Z; Fan J; Wang X; He D; Guo P
    FEBS Lett; 2016 Feb; 590(3):408-18. PubMed ID: 26786295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KLF5 inhibits angiogenesis in PTEN-deficient prostate cancer by attenuating AKT activation and subsequent HIF1α accumulation.
    Ci X; Xing C; Zhang B; Zhang Z; Ni JJ; Zhou W; Dong JT
    Mol Cancer; 2015 Apr; 14():91. PubMed ID: 25896712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Krüppel-like factor 5 promotes breast cell proliferation partially through upregulating the transcription of fibroblast growth factor binding protein 1.
    Zheng HQ; Zhou Z; Huang J; Chaudhury L; Dong JT; Chen C
    Oncogene; 2009 Oct; 28(42):3702-13. PubMed ID: 19668233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circular RNA MYLK as a competing endogenous RNA promotes bladder cancer progression through modulating VEGFA/VEGFR2 signaling pathway.
    Zhong Z; Huang M; Lv M; He Y; Duan C; Zhang L; Chen J
    Cancer Lett; 2017 Sep; 403():305-317. PubMed ID: 28687357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Krüppel-like factor 8 regulates VEGFA expression and angiogenesis in hepatocellular carcinoma.
    Cheng S; Zhang X; Xu Y; Dai X; Li J; Zhang T; Chen X
    Sci Rep; 2018 Nov; 8(1):17415. PubMed ID: 30479372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CCL5/CCR5 axis induces vascular endothelial growth factor-mediated tumor angiogenesis in human osteosarcoma microenvironment.
    Wang SW; Liu SC; Sun HL; Huang TY; Chan CH; Yang CY; Yeh HI; Huang YL; Chou WY; Lin YM; Tang CH
    Carcinogenesis; 2015 Jan; 36(1):104-14. PubMed ID: 25330803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CINP is a novel cofactor of KLF5 required for its role in the promotion of cell proliferation, survival and tumor growth.
    Wu Q; Fu C; Li M; Li J; Li Z; Qi L; Ci X; Ma G; Gao A; Fu X; A J; An N; Liu M; Li Y; King JL; Fu L; Zhang B; Dong JT
    Int J Cancer; 2019 Feb; 144(3):582-594. PubMed ID: 30289973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased REG1α expression suppresses growth, invasion and angiogenesis of bladder cancer.
    Geng J; Fan J; Wang Q; Zhang XP; Kang L; Li QY; Xu YF; Peng B; Zheng JH; Yao XD
    Eur J Surg Oncol; 2017 Apr; 43(4):837-846. PubMed ID: 28209239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The interplay between TEAD4 and KLF5 promotes breast cancer partially through inhibiting the transcription of p27Kip1.
    Wang C; Nie Z; Zhou Z; Zhang H; Liu R; Wu J; Qin J; Ma Y; Chen L; Li S; Chen W; Li F; Shi P; Wu Y; Shen J; Chen C
    Oncotarget; 2015 Jul; 6(19):17685-97. PubMed ID: 25970772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNMT1-maintained hypermethylation of Krüppel-like factor 5 involves in the progression of clear cell renal cell carcinoma.
    Fu RJ; He W; Wang XB; Li L; Zhao HB; Liu XY; Pang Z; Chen GQ; Huang L; Zhao KW
    Cell Death Dis; 2017 Jul; 8(7):e2952. PubMed ID: 28749461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulatory crosstalk between lineage-survival oncogenes KLF5, GATA4 and GATA6 cooperatively promotes gastric cancer development.
    Chia NY; Deng N; Das K; Huang D; Hu L; Zhu Y; Lim KH; Lee MH; Wu J; Sam XX; Tan GS; Wan WK; Yu W; Gan A; Tan AL; Tay ST; Soo KC; Wong WK; Dominguez LT; Ng HH; Rozen S; Goh LK; Teh BT; Tan P
    Gut; 2015 May; 64(5):707-19. PubMed ID: 25053715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Large-scale real-time reverse transcription-PCR approach of angiogenic pathways in human transitional cell carcinoma of the bladder: identification of VEGFA as a major independent prognostic marker.
    Pignot G; Bieche I; Vacher S; Güet C; Vieillefond A; Debré B; Lidereau R; Amsellem-Ouazana D
    Eur Urol; 2009 Oct; 56(4):678-88. PubMed ID: 18513850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KLF5 enhances SREBP-1 action in androgen-dependent induction of fatty acid synthase in prostate cancer cells.
    Lee MY; Moon JS; Park SW; Koh YK; Ahn YH; Kim KS
    Biochem J; 2009 Jan; 417(1):313-22. PubMed ID: 18774944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High concentrations of uric acid inhibit angiogenesis via regulation of the Krüppel-like factor 2-vascular endothelial growth factor-A axis by miR-92a.
    Yu S; Hong Q; Wang Y; Hou K; Wang L; Zhang Y; Fu B; Zhou Y; Zheng W; Chen X; Wu D
    Circ J; 2015; 79(11):2487-98. PubMed ID: 26299712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-6086 inhibits ovarian cancer angiogenesis by downregulating the OC2/VEGFA/EGFL6 axis.
    Wu B; Zhang L; Yu Y; Lu T; Zhang Y; Zhu W; Song Q; Lv C; Guo J; Tian Y; Deng N
    Cell Death Dis; 2020 May; 11(5):345. PubMed ID: 32393810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heme oxygenase-1 promotes angiogenesis in urothelial carcinoma of the urinary bladder.
    Miyake M; Fujimoto K; Anai S; Ohnishi S; Kuwada M; Nakai Y; Inoue T; Matsumura Y; Tomioka A; Ikeda T; Tanaka N; Hirao Y
    Oncol Rep; 2011 Mar; 25(3):653-60. PubMed ID: 21206978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Curcumin promotes KLF5 proteasome degradation through downregulating YAP/TAZ in bladder cancer cells.
    Gao Y; Shi Q; Xu S; Du C; Liang L; Wu K; Wang K; Wang X; Chang LS; He D; Guo P
    Int J Mol Sci; 2014 Aug; 15(9):15173-87. PubMed ID: 25170806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.